[Pharmaceutical device of IFN].

Article Details

Citation
Copy to clipboard

Higuchi Y, Hashida M

[Pharmaceutical device of IFN].

Nihon Rinsho. 2006 Jul;64(7):1374-9.

PubMed ID
16838659 [ View in PubMed
]
Abstract

Recently, new types of interferon (IFN) agents, such as pegylated IFN (PEG-IFN) and consensus IFN, have been developed for strong therapeutic effect and used in clinical stage. PEG-IFN, which is the conjugation of IFN and polyethylene glycol, was designed to long circulate in blood and decrease antibody production. Consensus IFN was designed to combine amino acid frequently appeared in IFN-alpha subtypes. Although they improved IFN therapy, it is also important to pay attention to side effect. Characteristics of new type IFN agents were summarized focused on their pharmaceutical designs.

DrugBank Data that Cites this Article

Drugs